NexImmune, Inc. Profile Avatar - Palmy Investing

NexImmune, Inc.

NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its p…

Biotechnology
US, Gaithersburg [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

NexImmune, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

NexImmune, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of NexImmune, Inc..

End of NEXI's Analysis
CIK: 1538210 CUSIP: 65344D109 ISIN: US65344D2080 LEI: - UEI: -
Secondary Listings
NEXI has no secondary listings inside our databases.